Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
Rituximab-abbs injection is used alone or together with other cancer medicines to treat a type of cancer called non-Hodgkin's lymphoma (NHL). It helps the immune system destroy cancer cells. Rituximab-abbs is a monoclonal antibody.
Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to treat chronic lymphocytic leukemia (CLL).
Rituximab-abbs injection is used together with methotrexate to treat the symptoms of moderate-to-severely-active rheumatoid arthritis. It helps to keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, or infliximab) did not work well. The use of rituximab-abbs injection in rheumatoid arthritis without previous treatment with these medicines is not recommended.
Rituximab-abbs injection is used together with steroids to treat granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). These are immune disorders that cause blood vessels to be inflamed.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: